Veracyte Inc Equity-NMS: VCYT

Healthcare

Diagnostics & Research

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$28.47
Open :$27.64
Today's high :$29.43
Today's low :$27.5
52W low :$18.61
52W high :$47.3162
EPS(TTM): :0.31
Shares O/S :77.94 M
Market cap :2.26 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Veracyte Inc $28.95 +0.81% 91.84 2.26B

Frequently Asked Questions

What is the share price of Veracyte Inc today?

Veracyte Inc (VCYT) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Veracyte Inc

Veracyte, Inc. is a global diagnostics company. The Company enables clinicians with insights they need to guide and help patients to diagnose and treat cancer. The Veracyte Diagnostics Platform delivers cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and an evidence-generation engine, which drives durable reimbursement and guideline inclusion for its tests, along with new insights to support continued innovation and pipeline development. The Company offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna) and bladder cancer (Decipher Bladder). It has developed the noninvasive Percepta Nasal Swab test to help physicians accurately and quickly determine lung cancer risk. All of its tests are serviced through its own Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in South San Francisco, California, San Diego, California and Austin, Texas.